Poster Presentations
Due to the large amount of poster received for this event, posters will be dotted around and organised as such:
• Posters noted (SE) are displayed in the back of Screening Europe conference rooms and in the exhibition hall.
• Posters noted (ADMET) are displayed in the back of ADMET Europe conference room.
• Posters noted (MCE) are displayed in the back of MedChem Europe conference room.
101(SE) - The Development of a Multiplex Polymerase Chain Reaction Based Assay for Bacterial Water Monitoring
Fatme Al-Anouti, Assistant Professor and Sarra Hisham Al Hasani, Student, Zayed University
102(SE) - Measurement of Low Levels of cAMP Using a New Enzyme Fragment Complementation (EFC) Competitive Immunoassay
Hayley Tinkler, Scientist, GE Healthcare
103(SE) - Receptor Selection and Amplification Technology: A Unique, Powerful Screening Platform for Drug Discovery
Fabrice Piu, Director Chemical Genomics, ACADIA Pharmaceuticals
104(SE) - High Throughput Kinase Selectivity Profiling for Drug Discovery Applications
Sinead Walsh, Applications Specialist, Deerac Fluidics
105(SE) - Assay Optimization and Kinase Profiling in uHTS Format
Devin Donnelly, European Sales & Distribution Manager, Deerac Fluidics
106(SE) - Comparison of an ELISA and FMAT Based Assay for Antibody Detection in Hybridoma Supernatant
Hans-Willi Krell, Senior Scientist, Roche Diagnostics GmbH
107(SE) - Frozen Cells in Microtiter Plates for Cell Based Screening
Oliver Klotzsche, Managing Director, CCS Cell Culture Service GmbH
108(SE) - Discovery, in vivo Activity and Mechanism of Action of a Small-Molecule P53 Activator
Sonia Lain, Lecturer, University of Dundee
109(SE) - Drug Discovery at Dundee - Targeting Trypanosoma Brucei Trypanothione Synthetase
Leah Torrie, Post-Doctoral Research Assistant, University of Dundee
110(SE) - Cell Cycle Analysis using a Triple Laser-Scanning Microplate Cytometer
Sarah Payne, Product Manager, TTP Labtech
111(SE) - Fluorescence Polarization Binding/Displacement Assay for HTS and Characterization Inhibitors of Basophilic Protein Kinases
Asko Uri, Leading Scientist, University of Tartu
112(SE) - Incorporating Tissue Architecture into Cellular Microchannel Assays Using Droplet-Based Passive Pumping
Steve Hayes, Principal Scientist, R&D, BellBrook Labs
113(SE) - Different Signalling Pathways Activated by Cannabinoid Receptor CB2
Roberta Petrò, Scientist II, Schering-Plough Research Institute
114(SE) - Detection of Protein Complexes in Native Cells Using in Situ PLA
Erik Nyström, Scientist, Olink Bioscience
115(SE) - Improving Efficiency by Assay Centralisation, Supporting Secondary Screening from Hit Identification Through Lead Optimisation
Darren Jones, Senior Scientist, AstraZeneca
116(SE) - Development of Generic c-myc Capture ELISA's Utilising Generic Anti-Phospho-Tyrosine Detection
Jon Orme, Senior Scientist, AstraZeneca
117(SE) - Establishing the Role of the Tubulin Ligand Index in the Development of Anti-Cancer Tubulin Ligands
Jean-François Têtu, Product Specialist, tebu-bio
118(SE) - Fluorescence-based Biochemical Assays for the Study of Pregnane X Receptor and Constitutive Androstane Receptor
Kaitlyn Van Den Heuvel-Kramer, Assoc. Product Manager, Invitrogen
119(SE) - Quantitative Analysis of Multiple Phosphorylation Events in Akt/Pi3-Kinase Signalling Pathway Using Mercator Phospho-Akt Pathway Arrays
Kaitlyn Van Den Heuvel-Kramer, Assoc. Product Manager, Invitrogen Corporation
120(SE) - Cannabinoid Receptor Cell Lines Utilizing The Tango™ Beta-Arrestin Recruitment Assay
Roland Leathers, Business Development Manager, Invitrogen
121(SE) - Selectivity Profiling Across the Entire Pi3 Kinase Family with the Europium-Based Universal Adapta™ Assay
Roland Leathers, Business Development Manager, Invitrogen
122(SE) - Click Chemistry-Based Detection of S-Phase Adherent Cells Using Automated Microscopy and Image Analysis
Mike Ignatius, Scientist/Product Manager, Molecular Probes/Invitrogen
123(SE) - Primary Cell Assays using BacMam Delivery, Combining Targets and Tools in a Relevant Physiological Setting
Kyle Gee, Scientist/Product Manager, Molecular Probes/Invitrogen
124(SE) - Transfer of Fluorescence-Based Protease and Kinase Assays onto a Novel Programmable Microfluidics Platform
Magali Kalala, SPINX- technologies
125(SE) - TINS: New Opportunities for Fragment Based Drug Discovery
Robert Heetebrij, Managing Director, ZoBio BV
126(SE) - RNAi Libraries Screening Platform as a Powerful Approach for Target Identification: The Example of the Glioblastoma Project
Pascale Nony, Scientific Manager, TRANSAT
127(SE) - From Target Identification to the Molecule: Walking the Way in Protein-Protein Interaction through the HIV-1 Integrase / Human LEDGF-Case Study
Philippe Guedat, Director, Chemistry, HYBRIGENICS SA
128(SE) - ES-Derived Cardiomyocytes Ready-to-Use from the Shelf
Heribert Bohlen, CEO, Axiogenesis AG
129(SE) - Optical Biosensor for Probing GPCR Ligand-Directed Functional Selectivity
Maria Torvinen, Applications Scientist, Epic System, Corning
130(SE) - Recombinant Soluble CCR5 Receptor: A New Crucial Target for Drug Discovery
Victoria Kurbatska, Researcher Assistant, ASLA Biotech
131(SE) - Beyond Kinases: Interrogating the Purinome
Karen Kleman-Leyer, Principal Scientist, BellBrook Labs
132(SE) - Transfer of Fluorescence-Based Protease and Kinase Assays onto a Novel Programmable Microfluidics Platform
Gregory Werner, Head of Sales, Europe, SpinX Technologies
133(SE) - HepaRG Hepatocytes: An Alternative to Human Primary Hepatocytes for Early ADME/Tox Studies
Nathalie Rougier, R & D Chief, BIOPREDIC INTERNATIONAL
134(SE) - Glowing and Flashing Aequorins for Measuring GPCR-Mediated Intracellular Calcium Flux
Matthew Hsu, R&D Director, Cell-Based Assays, Millipore Bioscience Division
135(SE) - Detection of Allosteric Potentiators for GPCRs with Millipore’s GPCR Profiler Platform
Matthew Hsu, R&D Director, Cell-Based Assays, Millipore Bioscience Division
136(SE) - New Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)
Jörg Schemies, Graduate Student, Albert-Ludwigs-Universität Freiburg
137(SE) - Cytotoxicity or Viability Measurement – Which Should You Use?
Stefan Graupner, Export Manager, Lonza Verviers
138(SE) - Robust Automated Methods for Screening of Histidine-Tagged and GST – Tagged Proteins From Crude Cell Extract
Helena Hedlund, Product Manager, GE Healthcare Life Sciences
139(SE) - Use of DNA Specific Anthraquinone Dyes to Directly Reveal Cytoplasmic and Nuclear Boundaries in Live and Fixed Cells
Roy Edward, Sales & Marketing Director, Biostatus Ltd
140(SE) - A Novel Hydrogel Mountant - Cygel™ - Enables Temporospatial HCS Imaging Assays of Live Non-Adherent Cells
Roy Edward, Sales & Marketing Director, Biostatus Ltd
141(SE) - Screening of Protein Kinases on Chemical Microarrays Using SPR Imaging Technology
Renate Sekul, VP R&D, Graffinity Pharmaceuticals
142(SE) - Stem Cell-Derived Neurons in CNS Drug Discovery
Bodo Spori, Business Development Manager, Scottish Biomedical And Laura Jackson, Project Manager, Stemcell Services
143(SE) - Near Real Time Detection Of Very Low Microbial Concentrations Using Impedimetric Chips
Jordi Mas, Microbiology Professor, Universitat Autònoma De Barcelona
144(SE) - An Automated Electroporation System for High-Throughput Transfection
Jon Sinclair, VP R&D, Cellectricon
145(SE) - A Genome-Wide Loss of Function Screen Identifies New Genes Required for Lung Cancer Cell Proliferation
Guillaume Pinna, Research Engineer, CNRS
146(SE) - Screening for Antimicrobial Agents from Natural Compounds Against Staphylococcus Aureus Biofilms in an Automated Environment
Malena Sandberg, PhD Student, Åbo Akademi University
147(SE) - Screening Approach For GPCR- Interacting Compounds Using a Miniaturized Radio-ligand Assay in an Automated Environment
Adyary Fallarero Linares, Senior Researcher, Åbo Akademi University
148(SE) - Expression and Purification of PI3 Kinase Alpha and Development of a Luminometric PI3 Kinase Activity Assay
Brigitte Boldyreff, CEO, KinaseDetect ApS
201(MCE) - Molecular Electronic Properties in the Design of Cytochrome bc1 Inhibitors as Potential Antimalarials
Tiago Rodrigues, PhD Student, Faculty of Pharmacy, University of Lisbon
202(MCE) - Prepartaion of Anti-Alphafeto Protein Monoclonal Antibodies Utilizing in ELISA Kit
Falah Abbas, Director of Enzyme Immuno Assay Lab, Ministry of Sciences and Technology
203(MCE) - Automated QSAR Modelling to Guide Drug Design
Matthew Segall, Senior Director ADMET, BioFocus DPI
204(MCE) - Synthesis and Antimalarial Activity of Artemisinin Aminoacid Derivatives
Rita Capela, PhD Student, Faculty of Pharmacy, University of Lisbon
205(MCE) - Synthesis, Antimalarial Activity and Intracellular Targets of a New Hybrid Molecule
Nubia Boechat, Head of R&D Group, Oswaldo Cruz Fundation- Fiocruz
206(MCE) - Design, Synthesis and Biological Evaluation of Potential MMP-2 Inhibitors
AMRI
207(MCE) - Routes to Substituted 4-ACPCA and TACA Derivatives to Give Novel GABA Analogues
Katherine Locock, PhD Student, University of Sydney
208(MCE) - Synthesis and Biochemical Evaluation of Novel Anti-Mitotic and Anti-Vascular Compounds
Niamh O'Boyle, Research Postgraduate, University of Dublin, Trinity College
209(MCE) - Molecular Modelling Studies on Novel Combretastatin A-4 Analogues
Niamh O'Boyle, Research Postgraduate, University of Dublin, Trinity College
210(MCE) - Palladium-Catalyzed Three-Component Approach to Promazine with Formation of One Carbon-Sulfur and Two Carbon-Nitrogen Bonds
Morten Jørgensen, Medicinal Chemist, H. Lundbeck A/S
211(MCE) - Virtual Screening by Quality-Driven Bioactive Conformations and Pharmacophore-Biased Creative Pharmacophore Search. Part II - Scaling-up
Anatoliy Nasonov, ChemoSoft Project Manager, ChemDiv Inc
212(MCE) - Novel and Promising HSP90 Inhibitors
Jens Norrild, Project Manager, Topotarget A/S
213(MCE) - Combinatorial Synthesis of Oxazolidin-2-Ones Using Fmoc-Ser(Trt)-OH, a Library with High Degree of Diversity
Miroslav Havranek, Head Of Chemistry Department, RE&D VUFB, S.R.O.
214(MCE) - Reaction Between 3-Carbothiamides of 2H-Pyrane-2-One With Hydrazine Hydrate
Malika Makhloufi-Chebli, Student in Heterocyclic Chemistry, Université des Sciences et de la Technologie Houari Boumedienne
216(MCE) - Some Biological Properties of Triterpenoid Acids
Svetlana Morozkina, Assist. Professor, Saint-Petersburg State University
217(MCE) - The Osteoprotective Action of 6-OXA-8a-Analogues of Steroid Estrogens
Alexander Shavva, Head of the Department, Saint-Petersburg State University
215(MCE) - Myristoyl CoA:Protein N-Myristoyl Transferase: A Target for a Novel Anti-Malarial Drug
Franziska Meier, Phd Student, Imperial College London
301(ADMET) - Simulation Modelling of Human Intestinal Absorption Using Caco-2 Permeability and Kinetic Solubility Data for Early Drug Discovery
Helen Gill, Product Development Manager, Cyprotex Discovery
302(ADMET) - In Silico Modelling of the SQSTM1/p62 UBA Domain – Ubiquitin Complex: Combining Protein-Protein Docking and Computational Mutagenesis
Philippe Manivet, Scientific Expert, Bioquanta
303(ADMET) - Modeling Blood-Brain Barrier Permeability by Passive Diffusion
Paulius Jurgutis, Director Communications, Pharma Algorithms Inc.
304(ADMET) - Modeling Permeability Across Caco-2 Monolayers
Pranas Japertas, Director Product Development, Pharma Algorithms Inc.
305(ADMET) - Probabilistic Prediction of the Human CYP3A4 Metabolism Sites in a Molecule
Andrius Sazonovas, Manager ADME/Tox, Pharma Algorithms Inc.
306(ADMET) - Development of a High-Througput Microarray for Evaluating CYP1A1 Induction
Megan Mason, Graduate Student, Rensselaer Polytechnic Institute
307(ADMET) - A Walk-Up ADME Testing System for Medicinal Chemists and Pharmacologists
Paul Oakley, Regional Manager, Syrris Ltd
308(ADMET) - High Sensitive Detection 0f Native Mistletoe Lectin in Human Serum Samples
Ron Wacker, Product Manager, Chimera Biotech
309(ADMET) - Not Only Data but Answers - Getting Typical ADME Parameters Directly from Your LCMS Software with High Throughput
Michael Frank, Product Manager Pharmaceutical Solutions, Agilent Technologies
310(ADMET) - An Interweaved multi-Algorithm Approach for Computer-Assisted - Identification of Drug Metabolites
Edgar Naegele, R&D and Marketing, Agilent Technologies
311(ADMET) - An Automated LC/MS/MS Protocol to Enhance Throughput of Physico-Chemical Property Profiling in Drug Discovery
Darcy Shave, Business Manager, Waters Corporation